Market Segmentation

One cannot discuss an industry perspective on pharmacogenomics without addressing the traditional concern of segmenting the market for a given drug such that sales and revenues will be significantly decreased. This has implications for both investment and drug pricing, as the cost of developing and marketing a drug with a narrow target population may be similar to that of developing a "blockbuster" drug (53).

It has become clear within oncology, however, that not only can this approach be profitable (54), but developing drugs specifically targeting a genomic aberration that is understood from the outset can also result in significantly reduced development times and costs, as in the above-cited case of dasatinib.

Identification of patients who would not have otherwise qualified by virtue of a novel test, as has been the case for the use of imatinib in gastrointestinal stromal tumors that express a mutated KIT receptor, and increased treatment duration and compliance linked to prolongation of survival or efficacy in the adjuvant setting. In the final analysis, a significant clinical benefit can be expected to lead to higher adoption rates.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment